SH3BP2 and cherubism: Chrcanovic et al. [19] therefore recognized the symptom onset at 2–3 years as the basic context of our 2005 work [2] and concluded that “interactions between SH3BP2-dependent signal transduction pathways and mechanisms involved in tooth development and jaw morphogenesis have been proposed to explain the rate of molar agenesis in patients with cherubism.